CONSISTENT AND RAPID CLINICAL BENEFIT FROM SYSTEMATIC BEVACIZUMAB-BVZR IN ADULT PATIENTS WITH HPV-ASSOCIATED RECURRENT RESPIRATORY PAPILLOMATOSIS

Authors
Category Primary study
Conference40th Annual Meeting of Society for Immunotherapy of Cancer, SITC 2025
Year 2025
This article has no abstract
Epistemonikos ID: 837d28166c5452934043344283a169120474c642
First added on: Dec 12, 2025